| ID: | 141 | |
|---|---|---|
| Name: | Compound 141 | |
| Description: | Original numeration in publication: 6h | |
| Labels: | Training_set, Phthalazines | |
| CAS: | ||
| InChi Code: | InChI=1S/C29H23N5O2/c1-36-24-17-11-20(12-18-24)19-30-34-29(35)22-13-15-23(16-14-22)31-28-26-10-6-5-9-25(26)27(32-33-28)21-7-3-2-4-8-21/h2-19H,1H3,(H,31,33)(H,34,35)/b30-19+ |
pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]
| Value | Source or prediction |
|---|---|
| 6.22 |
El-Adl, K.; Ibrahim, M. K.; Khedr, F. a. A., H. S.; Eissa, I. H. Design, synthesis, docking, and anticancer evaluations of phthalazines as VEGFR-2 inhibitors. Arch. Pharm. (Weinheim) 2022, 355, e2100278. https://doi.org/10.1002/ardp.202100278 |
| 6.38923 |
Eq1: VEGFR-2 inhibition (Data used to train model) |